Form 4: Arvinas Inc. Executive Noah Berkowitz Reports Stock and Option Grants

Chief Medical Officer Noah Berkowitz reports the acquisition of restricted stock units and stock options in Arvinas, Inc.

Summary

• On February 13, 2025, Noah Berkowitz, Chief Medical Officer of Arvinas, Inc., was granted 55,229 restricted stock units (RSUs) and an option to purchase 84,330 shares of common stock.
• The RSUs will vest over four years, with 25% vesting annually on February 13th from 2026 to 2029, contingent upon continued service.
• The stock options, with an exercise price of $17.67, also vest over four years, with 1/4 vesting on February 13, 2026, and the remainder in equal monthly installments until February 13, 2029, subject to continued service.
• Following these transactions, Berkowitz beneficially owns 118,681 shares of Arvinas common stock and options for 84,330 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grants are standard practice and incentivize the executive, but don't represent a major shift in the company's outlook.

Positives

• The grant of RSUs and stock options to the Chief Medical Officer aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment and performance from the executive.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the reporting person's continued service with the Issuer on each vesting date.

Industry Context

Stock option and RSU grants are a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Executive compensation packages in biotech companies like Arvinas often include a mix of salary, stock options, and restricted stock units.
• Companies such as Amgen, Gilead Sciences, and Biogen also utilize similar compensation structures to align executive interests with shareholder value.
• The vesting schedules are fairly standard, typically spanning three to four years to encourage long-term commitment.

Stakeholder Impact

• Shareholders may view the grants positively as they align executive interests with long-term company performance.
• Employees may see the grants as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Arvinas, Berkowitz, stock options, restricted stock units, RSUs, Form 4, insider trading, executive compensation